The COVID-19 pandemic has spawned global health crisis of unprecedented magnitude,
claiming millions of lives and pushing healthcare systems in many countries to the brink …

Abstract Coronavirus disease 2019 (COVID-19) causes acute microvascular thrombosis in
both venous and arterial structures which is highly associated with increased mortality. The …

Introduction While complement is a contributor to disease severity in severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, all three complement …

Introduction Mannose-binding lectin (MBL) promotes opsonization, favoring phagocytosis
and activation of the complement system in response to different microorganisms, and may …

Abstract COVID‐19 and ME/CFS present with some similar symptoms, especially physical
and mental fatigue. In order to understand the basis of these similarities and the possibility of …

Determining the genetic contribution of susceptibility to severe SARS-CoV-2 infection
outcomes is important for public health measures and individualized treatment. Through …

COVID-19 is characterized by a heterogeneous clinical presentation and prognosis. Risk
factors contributing to the development of severe disease include old age and the presence …

Risk stratification of coronavirus disease-19 (COVID-19) patients by simple markers is
critical to guide treatment. We studied the predictive value of soluble interleukin-2 receptor …

Background/Aim: The lung-specific soluble lectins, SP-A and SP-D have been clinically
used to diagnose interstitial lung disease, but their clinical significance in COVID-19 remains …

Background Mannose-binding lectin (MBL) is a member of innate immunity and acts with
MASP (MBL-associated serine protease) to activate the lectin pathway of the complement …